ReviewInternational journal of chronic obstructive pulmonary disease2012

Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD.

Roland Buhl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.